Articles of note for people dealing with pituitary disease and related conditions.
Join a drug trial. Find out how. Here’s a partial list of studies.
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Traumatic Brain Injury and the endocrine system on Live Talk: Thursday May 26, 3:00 pm PST
Tamara Wexler MD, Ph.D., joins us this week to talk about pituitary damage and insufficiency as a result of head trauma. Dr. Wexler is a Clinical Associate Professor in the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. Her research interests focus on the neuroendocrine and reproductive endocrine systems, particularly on changes that may occur after traumatic brain injury (TBI). This promises to be an excellent discussion. Tune in on Thursday!
Life After the Pandemic: Where do we go from here?
Has COVID-19 affected you or not? What narrative will you construct as time moves forward resulting from the events of recent years? Pausing to examine what you choose to derive is up to each person, but it is essential to know that the more a person decides to choose rather than allow the choice to be made for them, the more they can move forward and beyond. Having lived through a worldwide pandemic means we have all not only survived, but we’ve endured.
News In Brief
LIVE TALK sessions are now available on Demand. Click here to listen to past shows.
From Recordati Rare Diseases Phase III study confirms the efficacy and safety of ISTURISA®. achieving sustained cortisol control in the majority of patients. Read more
Good news from Amryt Pharma for acromegaly patients in Europe. Read the release from Amryt Pharma on Mycapssa® here.
Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome. Click here to learn more and see if you qualify.
Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study. To learn more about the trial and see if you qualify Read more here
Read more about clinical trials from Xeris Pharma, Camurus AB, and Ionis Ph
Content for physicians and healthcare professionals.
The latest from pharmaceutical companies and related organizations
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Dr. Lewis Blevins talks with guest Dr. Saleh Aldasouqi, Professor, Chief, Division of Endocrinology and Metabolism, and Clinician at Michigan State University Specialty Center, Endocrinology Clinic, about Biotin use and its interference with laboratory tests. This is definitely something you need to know to plan discontinuance of the supplement to allow for lab testing. You won’t want to miss this discussion. To learn more about this issue you can access the links we included in the article related to this podcasts with more details on the issues with Biotin use and how it can lead to misdiagnosis.
Our live talk session from May 12 is now available on-demand with guests Jill Sisco, president of the Acromegaly Community, and Sharmyn McGraw from the Pacific Neuroscience Institute. This was a fascinating perspective on the challenges and opportunities for patient advocacy programs with two of the leading patient advocates in the world of pituitary disease, specifically Cushing's and acromegaly. We talked about the voice of the patient initiatives, support groups, unmet needs, access to medication, and new initiatives to participate in making life better for people dealing with pituitary disease. Don't miss it, and join us next Thursday for another Live Talk session!
A highly informational "live-talk" session from Dr. Blevins. The first segment covers the indications for pituitary surgery for patients with pituitary adenomas. In the second half of the program, he discusses critical information for patients with Central Adrenal Insufficiency due to hypothalamic or pituitary disease.
Apple Podcasts
Spotify
Amazon Music
Google PodcastsMost Popular Articles
Events
Join us for the 2022 Acromegaly Community Hybrid Educational Conference. May 20-22, 2022 at the Embassy Suites Milpitas, California. More details, and registration here.
The conference is also available virtually! Please watch here to attend and participate live.
